Rapt Therapeutics IncNASDAQ:RAPT
- LAST PRICE27.9600
- TODAY'S CHANGE (%)0.5100 (1.8579%)
- Bid / Lots16.2200/ 1
- Ask / Lots35.2000/ 1
- Open / Previous Close27.4100 / 27.4500
- Day Range
- 52 Week Range
- Volume309,632
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RAPT |
|---|---|---|
| 09:32 ET | 1691 | 27.02 |
| 09:33 ET | 4093 | 27.38 |
| 09:35 ET | 300 | 27.67 |
| 09:42 ET | 1100 | 27.54 |
| 09:46 ET | 300 | 27.58 |
| 09:48 ET | 100 | 27.74 |
| 09:50 ET | 6365 | 28 |
| 09:51 ET | 592 | 28 |
| 09:53 ET | 1100 | 27.755 |
| 09:55 ET | 100 | 27.7 |
| 09:57 ET | 100 | 27.705 |
| 10:02 ET | 100 | 27.59 |
| 10:18 ET | 3002 | 27.91 |
| 10:20 ET | 4287 | 27.8 |
| 10:22 ET | 400 | 27.7 |
| 10:24 ET | 200 | 27.68 |
| 10:26 ET | 200 | 27.54 |
| 10:29 ET | 968 | 27.68 |
| 10:33 ET | 376 | 27.63 |
| 10:36 ET | 100 | 27.64 |
| 10:38 ET | 200 | 27.61 |
| 10:42 ET | 937 | 27.5 |
| 10:44 ET | 100 | 27.5 |
| 10:47 ET | 6264 | 27.5 |
| 10:49 ET | 2016 | 27.69 |
| 10:51 ET | 2163 | 27.63 |
| 10:56 ET | 20395 | 27.62 |
| 10:58 ET | 1917 | 27.675 |
| 11:00 ET | 900 | 27.72 |
| 11:02 ET | 2929 | 27.62 |
| 11:07 ET | 200 | 27.565 |
| 11:09 ET | 400 | 27.5 |
| 11:12 ET | 500 | 27.5 |
| 11:14 ET | 200 | 27.505 |
| 11:16 ET | 4382 | 27.56 |
| 11:18 ET | 600 | 27.64 |
| 11:20 ET | 200 | 27.68 |
| 11:21 ET | 934 | 27.79 |
| 11:25 ET | 641 | 27.74 |
| 11:30 ET | 100 | 27.665 |
| 11:32 ET | 100 | 27.71 |
| 11:34 ET | 1004 | 27.78 |
| 11:36 ET | 2600 | 27.85 |
| 11:41 ET | 100 | 27.94 |
| 11:43 ET | 615 | 27.94 |
| 11:45 ET | 129 | 27.96 |
| 11:48 ET | 100 | 27.905 |
| 11:50 ET | 200 | 27.96 |
| 11:52 ET | 200 | 27.915 |
| 11:54 ET | 300 | 27.87 |
| 11:57 ET | 100 | 27.83 |
| 12:01 ET | 100 | 27.82 |
| 12:08 ET | 200 | 27.78 |
| 12:10 ET | 315 | 27.78 |
| 12:12 ET | 704 | 27.66 |
| 12:15 ET | 700 | 27.76 |
| 12:17 ET | 200 | 27.715 |
| 12:19 ET | 600 | 27.78 |
| 12:21 ET | 400 | 27.85 |
| 12:24 ET | 200 | 27.93 |
| 12:28 ET | 200 | 27.84 |
| 12:32 ET | 100 | 27.785 |
| 12:35 ET | 300 | 27.795 |
| 12:37 ET | 100 | 27.84 |
| 12:42 ET | 1200 | 27.71 |
| 12:46 ET | 300 | 27.7 |
| 12:48 ET | 100 | 27.68 |
| 12:51 ET | 600 | 27.63 |
| 12:53 ET | 100 | 27.63 |
| 12:55 ET | 100 | 27.62 |
| 12:57 ET | 100 | 27.615 |
| 01:04 ET | 800 | 27.67 |
| 01:08 ET | 200 | 27.66 |
| 01:11 ET | 100 | 27.65 |
| 01:15 ET | 700 | 27.64 |
| 01:18 ET | 1200 | 27.74 |
| 01:20 ET | 300 | 27.83 |
| 01:22 ET | 300 | 27.79 |
| 01:24 ET | 300 | 27.73 |
| 01:26 ET | 100 | 27.68 |
| 01:29 ET | 200 | 27.74 |
| 01:31 ET | 100 | 27.735 |
| 01:33 ET | 400 | 27.755 |
| 01:36 ET | 500 | 27.75 |
| 01:38 ET | 100 | 27.68 |
| 01:42 ET | 2300 | 27.82 |
| 01:44 ET | 200 | 27.81 |
| 01:45 ET | 100 | 27.78 |
| 01:47 ET | 400 | 27.75 |
| 01:49 ET | 300 | 27.87 |
| 01:51 ET | 300 | 27.84 |
| 01:54 ET | 300 | 27.82 |
| 01:58 ET | 1301 | 27.9 |
| 02:00 ET | 4667 | 28.05 |
| 02:05 ET | 200 | 28.01 |
| 02:07 ET | 612 | 28.1 |
| 02:09 ET | 300 | 28.065 |
| 02:14 ET | 100 | 28 |
| 02:16 ET | 1000 | 27.97 |
| 02:18 ET | 100 | 27.99 |
| 02:20 ET | 400 | 27.965 |
| 02:21 ET | 332 | 28 |
| 02:25 ET | 300 | 28.025 |
| 02:32 ET | 900 | 27.97 |
| 02:34 ET | 300 | 28 |
| 02:36 ET | 100 | 28.04 |
| 02:38 ET | 400 | 28 |
| 02:43 ET | 100 | 28.025 |
| 02:45 ET | 600 | 28.025 |
| 02:48 ET | 1900 | 28.07 |
| 02:50 ET | 500 | 28.09 |
| 02:54 ET | 100 | 28.045 |
| 02:56 ET | 400 | 28.04 |
| 03:03 ET | 100 | 28.025 |
| 03:06 ET | 300 | 28.025 |
| 03:08 ET | 1000 | 28.02 |
| 03:10 ET | 100 | 28.04 |
| 03:12 ET | 500 | 28.055 |
| 03:14 ET | 700 | 27.93 |
| 03:15 ET | 450 | 27.905 |
| 03:17 ET | 320 | 27.92 |
| 03:19 ET | 500 | 27.96 |
| 03:21 ET | 100 | 27.99 |
| 03:24 ET | 400 | 28.01 |
| 03:26 ET | 1126 | 28 |
| 03:30 ET | 1799 | 27.96 |
| 03:32 ET | 100 | 27.96 |
| 03:33 ET | 1800 | 27.91 |
| 03:35 ET | 200 | 27.895 |
| 03:37 ET | 1100 | 27.845 |
| 03:39 ET | 500 | 27.83 |
| 03:42 ET | 804 | 27.815 |
| 03:44 ET | 1760 | 27.84 |
| 03:46 ET | 3816 | 27.98 |
| 03:48 ET | 2659 | 27.92 |
| 03:50 ET | 3147 | 27.92 |
| 03:51 ET | 3905 | 27.925 |
| 03:53 ET | 4680 | 27.85 |
| 03:55 ET | 5994 | 27.72 |
| 03:57 ET | 16990 | 27.875 |
| 04:00 ET | 33854 | 27.96 |
Jan 26, 2023
Insider Sell: Rapt Therapeutics, from 2:31PM ET on Thursday Jan 26, 2023 by MT Newswires
2:31PM ET on Thursday Jan 26, 2023 by MT Newswires
Jan 4, 2023
Wells Fargo Adjusts Price Target on RAPT Therapeutics to $48 From $55, Maintains Overweight Rating, from 10:27AM ET on Wednesday Jan 04, 2023 by MT Newswires
10:27AM ET on Wednesday Jan 04, 2023 by MT NewswiresGuggenheim Starts RAPT Therapeutics at Buy With $55 Price Target, from 9:35AM ET on Wednesday Jan 04, 2023 by MT Newswires
9:35AM ET on Wednesday Jan 04, 2023 by MT Newswires
Jan 3, 2023
RAPT Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference, from 8:00AM ET on Tuesday Jan 03, 2023 by GlobeNewswire
8:00AM ET on Tuesday Jan 03, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rapt Therapeutics Inc | 966.0M | -11.0x | --- |
IGM Biosciences Inc | 962.7M | -4.0x | --- |
Kura Oncology Inc | 931.1M | -6.7x | --- |
Janux Therapeutics Inc | 916.6M | -15.1x | --- |
Cogent Biosciences Inc | 1.0B | -5.8x | --- |
Arcutis Biotherapeutics Inc | 1.0B | -2.8x | --- |
Company Information
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. The Company is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in inflammatory diseases and oncology. Utilizing its drug discovery and development engine, the Company develops selective small molecules that are designed to modulate the critical immune responses underlying these diseases. Its two lead drug candidates each target C-C motif chemokine receptor 4 (CCR4). Its inflammation drug candidate, RPT193, is designed to selectively inhibit the migration of type 2 T helper cells (Th2 cells) into inflamed tissues. Its lead oncology drug candidate, FLX475, is designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors. In addition, RPT193 has clinical translatability in a variety of inflammatory diseases beyond atopic dermatitis (AD), including allergic asthma and chronic rhinosinusitis.
Contact Information
- Headquarters
- 561 Eccles AveSOUTH SAN FRANCISCO, CA, United States 94080-1906
- Phone
- 650-489-9000
- Fax
- 302-531-3150
Executives
- President, Chief Executive Officer, Director
- Brian Wong
- Chief Financial Officer, Principal Accounting Officer
- Rodney Young
- Chief Human Resource Officer
- Gwen Carscadden
- Chief Scientific Officer
- Dirk Brockstedt
- Chief Medical Officer
- William Ho
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $966.0M |
|---|---|
Revenue (TTM) | $2.3M |
Shares Outstanding | 34.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.54 |
Book Value | $6.31 |
P/E Ratio | -11.0x |
Price/Sales (TTM) | 423.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,477.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
